Gapping up
In reaction to earnings/guidance:
- LTHM +9.7%, SMCI +8.9%, AVDX +8.5%, UIS +8%, HSC +7.8%, ARWR +7.4%, SPNS +7.1%, FRSH +6.4%, GNRC +6.3%, EXPI +5%, INGR +5%, LFUS +4.8%, WU +4.6%, PRO +4.6%, BAND +4.5%, KAR +4.5% (also to rebrand as OPENLANE), DIN +4.2%, CRTO +4.2%, CCCS +3.8%, CWH +3.8%, CHEF +3.8%, ENLC +3.7%, EMR +3.6%, MTCH +3.5%, YUMC +3.2%, BLDR +3.2%, PERI +3.1%, COCO +2.8%, KHC +2.8%, LMAT +2.3%, ADNT +2.3%, OKE +2%, MCW +1.9%, UNM +1.9%, ASTE +1.9%, ATGE +1.8%, LUMN +1.7%, IONS +1.7%, OSW +1.6%, MUSA +1.5% (also authorizes new $1.5 bln share repurchase program), VRSK +1.3%, SBGI +1.3%, BFAM +1.2%, WWE +1.2%, CZR +1.1%, LNC +1% (also enters into $28 bln reinsurance transaction with Fortitude Re), BG +0.9%, TKR +0.9%
Other news:
- IMGN +95% (ELAHERE Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRa-Positive Platinum-Resistant Ovarian Cancer)
- COCO +2.8% (files for $200 mln mixed securities shelf offering; also files for offering by selling shareholders)
- GES +2.2% (names new CFO)
- VCYT +2% (reports data published in journal)
- INTC +1.8% (inverse sympathy with AMD earnings)
- MYRG +1% (authorizes new $75 mln share repurchase program)
Analyst comments:
- HSBC +1% (upgraded to Buy from Hold at Berenberg)
- BHP +0.8% (upgraded to Buy from Neutral at Goldman)
- MAR +0.7% (upgraded to Outperform from Mkt Perform at Bernstein)